Unicorn Pharmaceuticals Limited
Private Limited Company · Stanmore
ActiveUnited KingdomIncorporated 2023Private Limited Company
Financial position
Accounts to 2025-03-31 · GBP · unknown scope
Net assets
−£1,517,139
Cash
£134,747
Turnover
—
Profit / loss
—
Current assets
£871,980
Creditors < 1 year
£11,554
Equity
−£1,517,139
Average employees
4
Balance-sheet trend
GBP · unknownTwo periods with a known, matching scope are needed for a trend.
Financial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-03-31GBP · unknown | 2024-03-31GBP · unknown |
|---|---|---|
| Balance sheet | ||
| Net assets | −£1,517,139 | −£584,849 |
| Equity | −£1,517,139 | −£584,849 |
| Assets | ||
| Fixed assets | £622,115 | — |
| Intangible assets | £618,716 | — |
| Current assets | £871,980 | £622,484 |
| Cash at bank | £134,747 | £584,729 |
| Debtors | £737,233 | £37,755 |
| Liabilities | ||
| Creditors within one year | £11,554 | £7,312 |
| Creditors after one year | £2,999,680 | £1,200,021 |
| Net current assets | £860,426 | £615,172 |
| Assets less current liabilities | £1,482,541 | £615,172 |
| People | ||
| Average employees | 4 | 2 |
| Source evidence | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesFloating · created 2026-06-30
—
Outstanding